PL
PL · PL · PL-100482176
Pombiliti
ATC A16AB23
Last synced from URPL (Poland) on
Identification
ManufacturerAmicus Therapeutics Europe Limited
CountryPL (PL)
ATC codeA16AB23
Dispensing—
ReimbursedNo
SourceURPL (Poland)
Last synced6/14/2026
Packs · 0
No packs registered.
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Proszek do sporządzania koncentratu roztworu do infuzji",
"source": "urpl",
"strength": "105 mg",
"packaging": "Rpz ¦ EU/1/22/1714/001 ¦ 149811\n1 fiol. 105 mg\nRpz ¦ EU/1/22/1714/003 ¦ 149812\n25 fiol. 105 mg\nRpz ¦ EU/1/22/1714/002 ¦ 149813\n10 fiol. 105 mg",
"substance": "Cipaglucosidasum alfa 105 mg",
"common_name": "Cipaglucosidasum alfa",
"pl_product_id": "100482176",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}Related drugs
Other records sharing ATC code A16AB23.
- FIPombilitiAmicus Therapeutics Europe Limited
- NOPombilitiAmicus Therapeutics Europe Limited
- ISPombilitiAmicus Therapeutics Europe Limited*
- 🇨🇭Pombiliti
- 🇨🇭PombilitiAmicus Therapeutics Switzerland GmbH
- DKPombilitiAmicus Therapeutics Europe Ltd
- CZPOMBILITIAmicus Therapeutics Europe Limited, Dublin
- CZPOMBILITIAmicus Therapeutics Europe Limited, Dublin
Access this data programmatically
Query Pombiliti and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.